HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideo Harigae Selected Research

5-Aminolevulinate Synthetase

1/2022Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
2/2014Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
6/2012The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability.
12/2010[Recent progress in iron metabolism and iron-related anemia].
6/2003Late-onset X-linked sideroblastic anemia following hemodialysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideo Harigae Research Topics

Disease

21Neoplasms (Cancer)
09/2022 - 12/2004
15Lymphoma (Lymphomas)
01/2022 - 03/2002
14Sideroblastic Anemia
01/2022 - 06/2003
14Infections
08/2021 - 04/2004
11X-linked sideroblastic anemia
01/2022 - 06/2003
11Leukemia
01/2019 - 06/2004
9Multiple Myeloma
01/2022 - 01/2009
9Anemia
01/2018 - 06/2003
8Rheumatoid Arthritis
06/2022 - 06/2010
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2020 - 01/2011
8Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 08/2005
7Inflammation (Inflammations)
11/2022 - 02/2016
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2022 - 12/2005
7B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2007
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2021 - 06/2002
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2011
5T-Cell Lymphoma (Lymphoma, T Cell)
04/2022 - 10/2006
5Autoimmune Diseases (Autoimmune Disease)
05/2021 - 01/2013
4Takayasu Arteritis (Arteritis, Takayasu's)
06/2022 - 11/2019
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2022 - 01/2009
4Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 09/2004
4Disease Progression
11/2018 - 01/2009
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2017 - 11/2011
4Hematologic Diseases (Blood Diseases)
03/2014 - 10/2003
3Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2022 - 01/2018
3Pathologic Complete Response
09/2022 - 07/2009
3Acute Promyelocytic Leukemia
01/2022 - 07/2008
3Fever (Fevers)
01/2022 - 02/2009
3Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2022 - 01/2009
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2016
3Exanthema (Rash)
01/2022 - 09/2004
3Vasculitis (Vasculitides)
05/2021 - 07/2012
3Systemic Scleroderma (Systemic Sclerosis)
01/2020 - 01/2016
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2019 - 10/2009
3Acute Erythroblastic Leukemia (Erythroleukemia)
01/2019 - 01/2015
3Thrombotic Thrombocytopenic Purpura
01/2017 - 01/2009
3Pain (Aches)
11/2016 - 02/2009
3Hepatitis B
01/2015 - 11/2013
3Collagen Diseases (Collagen Disease)
01/2013 - 01/2009
3Hemolytic Anemia
01/2013 - 01/2010
3Philadelphia Chromosome
07/2011 - 09/2004
2Eosinophilia
11/2022 - 01/2009
2Cerebral Hemorrhage
11/2022 - 09/2020
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2022 - 10/2006
2Dermatomyositis (Dermatopolymyositis)
01/2022 - 01/2016
2Polymyositis
01/2022 - 01/2016
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 04/2010
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 09/2018
2Renal Insufficiency (Renal Failure)
11/2021 - 01/2010
2Plasmacytoma
10/2021 - 03/2002
2Enteritis
05/2021 - 05/2010
2Diarrhea
05/2021 - 01/2012

Drug/Important Bio-Agent (IBA)

12Heme (Haem)IBA
01/2019 - 02/2002
10Rituximab (Mabthera)FDA Link
11/2022 - 07/2009
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2021 - 04/2004
10Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2003
10EnzymesIBA
11/2019 - 01/2010
10IronIBA
01/2019 - 10/2008
9Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022 - 01/2009
9AutoantibodiesIBA
01/2022 - 07/2009
9Prednisolone (Predate)FDA LinkGeneric
05/2021 - 07/2009
8AntibodiesIBA
01/2020 - 06/2003
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2003
6Transcription Factors (Transcription Factor)IBA
10/2018 - 06/2004
6CytokinesIBA
02/2016 - 11/2006
5Methotrexate (Mexate)FDA LinkGeneric
09/2022 - 04/2007
5Biological ProductsIBA
06/2022 - 01/2016
55-Aminolevulinate SynthetaseIBA
01/2022 - 06/2003
5Pharmaceutical PreparationsIBA
05/2021 - 08/2005
5Tacrolimus (Prograf)FDA LinkGeneric
10/2020 - 04/2007
5SulfurIBA
01/2019 - 10/2010
5Imatinib Mesylate (Gleevec)FDA Link
12/2015 - 09/2004
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2022 - 01/2018
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 11/2013
4Immunosuppressive Agents (Immunosuppressants)IBA
10/2020 - 12/2005
4SteroidsIBA
10/2020 - 06/2003
4Immunoglobulin G (IgG)IBA
11/2018 - 07/2012
4Messenger RNA (mRNA)IBA
02/2014 - 06/2002
3tocilizumab (atlizumab)FDA Link
06/2022 - 06/2010
3CreatinineIBA
01/2021 - 01/2010
3AutoantigensIBA
01/2020 - 01/2013
3Bortezomib (Velcade)FDA Link
11/2018 - 04/2009
2Brentuximab VedotinIBA
09/2022 - 05/2020
2Interleukin-6 (Interleukin 6)IBA
06/2022 - 01/2015
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2022 - 01/2012
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2022
2tisagenlecleucelIBA
01/2022 - 01/2022
2daratumumabIBA
10/2021 - 08/2019
2Peroxidase (Myeloperoxidase)IBA
05/2021 - 01/2018
2MethylprednisoloneFDA LinkGeneric
05/2021 - 06/2013
2Anti-Bacterial Agents (Antibiotics)IBA
05/2021 - 05/2020
2AlbuminsIBA
05/2021 - 06/2015

Therapy/Procedure

37Therapeutics
11/2022 - 06/2003
23Drug Therapy (Chemotherapy)
09/2022 - 12/2004
14Hematopoietic Stem Cell Transplantation
09/2022 - 09/2004
12Transplantation
06/2022 - 04/2004
7Stem Cell Transplantation
06/2022 - 04/2004
3Aftercare (After-Treatment)
06/2013 - 04/2010
2Induction Chemotherapy
09/2022 - 01/2022
2Platelet Transfusion (Blood Platelet Transfusions)
01/2022 - 10/2009